Selected research
Market Outlook & Growth Opportunities
Global AI-enabled Plaque Analysis Software Market Outlook and Growth Opportunities 2026
Market perspective
The global AI-enabled Plaque Analysis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AI-enabled Plaque Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI-enabled Plaque Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI-enabled Plaque Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AI-enabled Plaque Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AI-enabled Plaque Analysis Software market include Medis Medical Imaging, Cleerly, Heartflow, Artrya, Spimed-AI, Caristo Diagnostics, RSIP Vision, Circle and RadNet, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AI-enabled Plaque Analysis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI-enabled Plaque Analysis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI-enabled Plaque Analysis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-enabled Plaque Analysis Software market.
AI-enabled Plaque Analysis Software Segment by Company
Medis Medical Imaging
Cleerly
Heartflow
Artrya
Spimed-AI
Caristo Diagnostics
RSIP Vision
Circle
RadNet
Brainomix
RapidAI
Elucid
Shanghai United Imaging
Beijing Infervision Technology
Shanghai SenseTime
Shukun (Beijing) Technology
Shenzhen Ruixin Intelligent Medical Technology
AI-enabled Plaque Analysis Software Segment by Type
Quantitative Measurements
Qualitative Measurements
AI-enabled Plaque Analysis Software Segment by Application
Medical Research
Clinical Application
AI-enabled Plaque Analysis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AI-enabled Plaque Analysis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AI-enabled Plaque Analysis Software key companies, revenue, market share, and recent developments.
3. To split the AI-enabled Plaque Analysis Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AI-enabled Plaque Analysis Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AI-enabled Plaque Analysis Software significant trends, drivers, influence factors in global and regions.
6. To analyze AI-enabled Plaque Analysis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-enabled Plaque Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-enabled Plaque Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-enabled Plaque Analysis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-enabled Plaque Analysis Software industry.
Chapter 3: Detailed analysis of AI-enabled Plaque Analysis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AI-enabled Plaque Analysis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AI-enabled Plaque Analysis Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Quantitative Measurements
- Qualitative Measurements
Applications
- Medical Research
- Clinical Application
Companies covered
- Medis Medical Imaging
- Cleerly
- Heartflow
- Artrya
- Spimed-AI
- Caristo Diagnostics
- RSIP Vision
- Circle
- RadNet
- Brainomix
- RapidAI
- Elucid
- Shanghai United Imaging
- Beijing Infervision Technology
- Shanghai SenseTime
- Shukun (Beijing) Technology
- Shenzhen Ruixin Intelligent Medical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AI-enabled Plaque Analysis Software Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AI-enabled Plaque Analysis Software Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI-enabled Plaque Analysis Software Market Dynamics
- 2.1 AI-enabled Plaque Analysis Software Industry Trends
- 2.2 AI-enabled Plaque Analysis Software Industry Drivers
- 2.3 AI-enabled Plaque Analysis Software Industry Opportunities and Challenges
- 2.4 AI-enabled Plaque Analysis Software Industry Restraints
3 AI-enabled Plaque Analysis Software Market by Company
- 3.1 Global AI-enabled Plaque Analysis Software Company Revenue Ranking in 2025
- 3.2 Global AI-enabled Plaque Analysis Software Revenue by Company (2021-2026)
- 3.3 Global AI-enabled Plaque Analysis Software Company Ranking (2024-2026)
- 3.4 Global AI-enabled Plaque Analysis Software Company Manufacturing Base and Headquarters
- 3.5 Global AI-enabled Plaque Analysis Software Company Product Type and Application
- 3.6 Global AI-enabled Plaque Analysis Software Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AI-enabled Plaque Analysis Software Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AI-enabled Plaque Analysis Software Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AI-enabled Plaque Analysis Software Market by Type
- 4.1 AI-enabled Plaque Analysis Software Type Introduction
- 4.1.1 Quantitative Measurements
- 4.1.2 Qualitative Measurements
- 4.2 Global AI-enabled Plaque Analysis Software Sales Value by Type
- 4.2.1 Global AI-enabled Plaque Analysis Software Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AI-enabled Plaque Analysis Software Sales Value by Type (2021-2032)
- 4.2.3 Global AI-enabled Plaque Analysis Software Sales Value Share by Type (2021-2032)
5 AI-enabled Plaque Analysis Software Market by Application
- 5.1 AI-enabled Plaque Analysis Software Application Introduction
- 5.1.1 Medical Research
- 5.1.2 Clinical Application
- 5.2 Global AI-enabled Plaque Analysis Software Sales Value by Application
- 5.2.1 Global AI-enabled Plaque Analysis Software Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AI-enabled Plaque Analysis Software Sales Value by Application (2021-2032)
- 5.2.3 Global AI-enabled Plaque Analysis Software Sales Value Share by Application (2021-2032)
6 AI-enabled Plaque Analysis Software Regional Value Analysis
- 6.1 Global AI-enabled Plaque Analysis Software Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AI-enabled Plaque Analysis Software Sales Value by Region (2021-2032)
- 6.2.1 Global AI-enabled Plaque Analysis Software Sales Value by Region: 2021-2026
- 6.2.2 Global AI-enabled Plaque Analysis Software Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AI-enabled Plaque Analysis Software Sales Value (2021-2032)
- 6.3.2 North America AI-enabled Plaque Analysis Software Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AI-enabled Plaque Analysis Software Sales Value (2021-2032)
- 6.4.2 Europe AI-enabled Plaque Analysis Software Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AI-enabled Plaque Analysis Software Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AI-enabled Plaque Analysis Software Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AI-enabled Plaque Analysis Software Sales Value (2021-2032)
- 6.6.2 South America AI-enabled Plaque Analysis Software Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AI-enabled Plaque Analysis Software Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AI-enabled Plaque Analysis Software Sales Value Share by Country, 2025 VS 2032
7 AI-enabled Plaque Analysis Software Country-level Value Analysis
- 7.1 Global AI-enabled Plaque Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AI-enabled Plaque Analysis Software Sales Value by Country (2021-2032)
- 7.2.1 Global AI-enabled Plaque Analysis Software Sales Value by Country (2021-2026)
- 7.2.2 Global AI-enabled Plaque Analysis Software Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.7.2 France AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.14.2 China AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.17.2 India AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AI-enabled Plaque Analysis Software Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AI-enabled Plaque Analysis Software Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AI-enabled Plaque Analysis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Medis Medical Imaging
- 8.1.1 Medis Medical Imaging Company Information
- 8.1.2 Medis Medical Imaging Business Overview
- 8.1.3 Medis Medical Imaging AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.1.4 Medis Medical Imaging AI-enabled Plaque Analysis Software Product Portfolio
- 8.1.5 Medis Medical Imaging Recent Developments
- 8.2 Cleerly
- 8.2.1 Cleerly Company Information
- 8.2.2 Cleerly Business Overview
- 8.2.3 Cleerly AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.2.4 Cleerly AI-enabled Plaque Analysis Software Product Portfolio
- 8.2.5 Cleerly Recent Developments
- 8.3 Heartflow
- 8.3.1 Heartflow Company Information
- 8.3.2 Heartflow Business Overview
- 8.3.3 Heartflow AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.3.4 Heartflow AI-enabled Plaque Analysis Software Product Portfolio
- 8.3.5 Heartflow Recent Developments
- 8.4 Artrya
- 8.4.1 Artrya Company Information
- 8.4.2 Artrya Business Overview
- 8.4.3 Artrya AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.4.4 Artrya AI-enabled Plaque Analysis Software Product Portfolio
- 8.4.5 Artrya Recent Developments
- 8.5 Spimed-AI
- 8.5.1 Spimed-AI Company Information
- 8.5.2 Spimed-AI Business Overview
- 8.5.3 Spimed-AI AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.5.4 Spimed-AI AI-enabled Plaque Analysis Software Product Portfolio
- 8.5.5 Spimed-AI Recent Developments
- 8.6 Caristo Diagnostics
- 8.6.1 Caristo Diagnostics Company Information
- 8.6.2 Caristo Diagnostics Business Overview
- 8.6.3 Caristo Diagnostics AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.6.4 Caristo Diagnostics AI-enabled Plaque Analysis Software Product Portfolio
- 8.6.5 Caristo Diagnostics Recent Developments
- 8.7 RSIP Vision
- 8.7.1 RSIP Vision Company Information
- 8.7.2 RSIP Vision Business Overview
- 8.7.3 RSIP Vision AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.7.4 RSIP Vision AI-enabled Plaque Analysis Software Product Portfolio
- 8.7.5 RSIP Vision Recent Developments
- 8.8 Circle
- 8.8.1 Circle Company Information
- 8.8.2 Circle Business Overview
- 8.8.3 Circle AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.8.4 Circle AI-enabled Plaque Analysis Software Product Portfolio
- 8.8.5 Circle Recent Developments
- 8.9 RadNet
- 8.9.1 RadNet Company Information
- 8.9.2 RadNet Business Overview
- 8.9.3 RadNet AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.9.4 RadNet AI-enabled Plaque Analysis Software Product Portfolio
- 8.9.5 RadNet Recent Developments
- 8.10 Brainomix
- 8.10.1 Brainomix Company Information
- 8.10.2 Brainomix Business Overview
- 8.10.3 Brainomix AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.10.4 Brainomix AI-enabled Plaque Analysis Software Product Portfolio
- 8.10.5 Brainomix Recent Developments
- 8.11 RapidAI
- 8.11.1 RapidAI Company Information
- 8.11.2 RapidAI Business Overview
- 8.11.3 RapidAI AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.11.4 RapidAI AI-enabled Plaque Analysis Software Product Portfolio
- 8.11.5 RapidAI Recent Developments
- 8.12 Elucid
- 8.12.1 Elucid Company Information
- 8.12.2 Elucid Business Overview
- 8.12.3 Elucid AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.12.4 Elucid AI-enabled Plaque Analysis Software Product Portfolio
- 8.12.5 Elucid Recent Developments
- 8.13 Shanghai United Imaging
- 8.13.1 Shanghai United Imaging Company Information
- 8.13.2 Shanghai United Imaging Business Overview
- 8.13.3 Shanghai United Imaging AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.13.4 Shanghai United Imaging AI-enabled Plaque Analysis Software Product Portfolio
- 8.13.5 Shanghai United Imaging Recent Developments
- 8.14 Beijing Infervision Technology
- 8.14.1 Beijing Infervision Technology Company Information
- 8.14.2 Beijing Infervision Technology Business Overview
- 8.14.3 Beijing Infervision Technology AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.14.4 Beijing Infervision Technology AI-enabled Plaque Analysis Software Product Portfolio
- 8.14.5 Beijing Infervision Technology Recent Developments
- 8.15 Shanghai SenseTime
- 8.15.1 Shanghai SenseTime Company Information
- 8.15.2 Shanghai SenseTime Business Overview
- 8.15.3 Shanghai SenseTime AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.15.4 Shanghai SenseTime AI-enabled Plaque Analysis Software Product Portfolio
- 8.15.5 Shanghai SenseTime Recent Developments
- 8.16 Shukun (Beijing) Technology
- 8.16.1 Shukun (Beijing) Technology Company Information
- 8.16.2 Shukun (Beijing) Technology Business Overview
- 8.16.3 Shukun (Beijing) Technology AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.16.4 Shukun (Beijing) Technology AI-enabled Plaque Analysis Software Product Portfolio
- 8.16.5 Shukun (Beijing) Technology Recent Developments
- 8.17 Shenzhen Ruixin Intelligent Medical Technology
- 8.17.1 Shenzhen Ruixin Intelligent Medical Technology Company Information
- 8.17.2 Shenzhen Ruixin Intelligent Medical Technology Business Overview
- 8.17.3 Shenzhen Ruixin Intelligent Medical Technology AI-enabled Plaque Analysis Software Revenue and Gross Margin (2021-2026)
- 8.17.4 Shenzhen Ruixin Intelligent Medical Technology AI-enabled Plaque Analysis Software Product Portfolio
- 8.17.5 Shenzhen Ruixin Intelligent Medical Technology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst